Drug discovery: Estrogen-related compounds in mouse models of Alzheimer’s disease

By Smith Jonathan   Chakrabarti Enakshi   Levin-Allerhand Justine  

Journal of Molecular Neuroscience, Vol. 24, Iss. 1, 2004-02 ,pp. : 145-147

Humana Press, Inc

Access to resources Recommend Favorite

Tau as a Drug Target in Alzheimer’s Disease

By Gozes Illana  

Journal of Molecular Neuroscience, Vol. 19, Iss. 3, 2002-12 ,pp. : 337-338

Humana Press, Inc

Access to resources Recommend Favorite

Biomarkers to advance drug development for Alzheimer’s disease

By Schulman Howard  

Future Neurology, Vol. 1, Iss. 4, 2006-07 ,pp. : 409-415

Future Medicine

Access to resources Recommend Favorite

A Review of the Effects of Hypoxia, Sleep Deprivation and Transcranial Magnetic Stimulation on EEG Activity in Humans: Challenges for Drug Discovery for Alzheimer’s Disease

By  

Current Alzheimer Research, Vol. 11, Iss. 5, 2014-06 ,pp. : 501-518

Bentham Science Publishers

Access to resources Recommend Favorite

Glyceraldehyde-derived advanced glycation end products in Alzheimer’s disease

By Choei Hiroshi   Sasaki Nobuyuki   Takeuchi Masayoshi   Yoshida Taku   Ukai Wataru   Yamagishi Sho-ichi   Kikuchi Seiji   Saito Toshikazu  

Acta Neuropathologica, Vol. 108, Iss. 3, 2004-09 ,pp. : 189-193

Springer Publishing Company

Access to resources Recommend Favorite